Stocks and Investing
Stocks and Investing
Thu, August 18, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, August 17, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Gal Munda Initiated (SNPS) at Buy and Held Target at $440 on, Aug 17th, 2022
Gal Munda of Wolfe Research, Initiated "Synopsys, Inc." (SNPS) at Buy and Held Target at $440 on, Aug 17th, 2022.
Gal has made no other calls on SNPS in the last 4 months.
There are 6 other peers that have a rating on SNPS. Out of the 6 peers that are also analyzing SNPS, 1 agrees with Gal's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Vivek Arya of "B of A Securities" Upgraded from Sell to Hold and Increased Target to $360 on, Wednesday, June 29th, 2022
These are the ratings of the 5 analyists that currently disagree with Gal
- Blair Abernethy of "Rosenblatt" Maintained at Strong Buy with Increased Target to $390 on, Friday, August 12th, 2022
- Gary Mobley of "Wells Fargo" Maintained at Buy with Increased Target to $425 on, Thursday, August 11th, 2022
- Pradeep Ramani of "UBS" Maintained at Strong Buy with Decreased Target to $360 on, Thursday, May 19th, 2022
- Charles Shi of "Needham" Maintained at Strong Buy with Increased Target to $380 on, Thursday, May 19th, 2022
- Ruben Roy of "WestPark Capital" Maintained at Strong Buy with Decreased Target to $370 on, Monday, May 16th, 2022
Contributing Sources